Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

Free Publication Certificate

Vol. 8, Issue 5 (2019)

Development of specification for substance 7-azepan-1-il-1-ethil-6-ftor-3- (4-phenyl-1, 3-tiazol-2-il) - Quinoline-4 (1h)-one

Author(s):
Spyrydonova NV, Silin AV, Lebedynets VA, Zavada OA and Kalinenko OS
Abstract:
The paper presents the results of the development of specifications for a new first-synthesized chemical compound exhibiting antibacterial activity and positioned as a perspective drug substance. According to the recommendations of the European Pharmacopoeia quality control procedures have been developed for standardization the substance of 7-azepan-1-yl-1-ethyl-6-fluoro-3-(4-phenyl-1,3-thiazol-2-yl))-quinoline-4(1H)-one - a modified derivative of the fluoroquinolone series.
Pages: 54-56  |  1166 Views  133 Downloads


The Pharma Innovation Journal
How to cite this article:
Spyrydonova NV, Silin AV, Lebedynets VA, Zavada OA, Kalinenko OS. Development of specification for substance 7-azepan-1-il-1-ethil-6-ftor-3- (4-phenyl-1, 3-tiazol-2-il) - Quinoline-4 (1h)-one. Pharma Innovation 2019;8(5):54-56.

Call for book chapter